Impact of cancer-related fatigue on the lives of patients

New findings from the fatigue coalition

G. A. Curt, W. Breitbart, D. Cella, J. E. Groopman, S. J. Horning, L. M. Itri, D. H. Johnson, C. Miaskowski, S. L. Scherr, R. K. Portenoy, N. J. Vogelzang

Research output: Contribution to journalArticle

767 Citations (Scopus)

Abstract

Purpose. This survey was designed to confirm the prevalence and duration of fatigue in the cancer population and to assess its physical, mental, social, and economic impacts on the lives of patients and caregivers. Patients and Methods. A 25-minute telephone interview was completed with 379 cancer patients having a prior history of chemotherapy. Patients were recruited from a sample of 6,125 households in the United States identified as having a member with cancer. The median patient age was 62 years, and 79% of respondents were women. Patients reporting fatigue at least a few times a month were asked a series of questions to better describe their fatigue and its impact on quality of life. Results. Seventy-six percent of patients experienced fatigue at least a few days each month during their most recent chemotherapy; 30% experienced fatigue on a daily basis. Ninety-one percent of those who experienced fatigue reported that it prevented a 'normal' life, and 88% indicated that fatigue caused an alteration in their daily routine. Fatigue made it more difficult to participate in social activities and perform typical cognitive tasks. Of the 177 patients who were employed, 75% changed their employment status as a result of fatigue. Furthermore, 65% of patients indicated that their fatigue resulted in their caregivers taking at least one day (mean, 4.5 days) off work in a typical month. Physicians were the health care professionals most commonly consulted (79%) to discuss fatigue. Bed rest/relaxation was the most common treatment recommendation (37%); 40% of patients were not offered any recommendations. Conclusions. Cancer-related fatigue is common among cancer patients who have received chemotherapy and results in substantial adverse physical, psychosocial, and economic consequences for both patients and caregivers. Given the impact of fatigue, treatment options should be routinely considered in the care of patients with cancer.

Original languageEnglish (US)
Pages (from-to)353-360
Number of pages8
JournalOncologist
Volume5
Issue number5
StatePublished - 2000

Fingerprint

Fatigue
Neoplasms
Caregivers
Drug Therapy
Economics
Bed Rest
Patient Care
Quality of Life
Interviews
Delivery of Health Care
Physicians

Keywords

  • Asthenia
  • Cancer
  • Chemotherapy
  • Fatigue
  • Fatigue Coalition
  • Quality of life

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Curt, G. A., Breitbart, W., Cella, D., Groopman, J. E., Horning, S. J., Itri, L. M., ... Vogelzang, N. J. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from the fatigue coalition. Oncologist, 5(5), 353-360.

Impact of cancer-related fatigue on the lives of patients : New findings from the fatigue coalition. / Curt, G. A.; Breitbart, W.; Cella, D.; Groopman, J. E.; Horning, S. J.; Itri, L. M.; Johnson, D. H.; Miaskowski, C.; Scherr, S. L.; Portenoy, R. K.; Vogelzang, N. J.

In: Oncologist, Vol. 5, No. 5, 2000, p. 353-360.

Research output: Contribution to journalArticle

Curt, GA, Breitbart, W, Cella, D, Groopman, JE, Horning, SJ, Itri, LM, Johnson, DH, Miaskowski, C, Scherr, SL, Portenoy, RK & Vogelzang, NJ 2000, 'Impact of cancer-related fatigue on the lives of patients: New findings from the fatigue coalition', Oncologist, vol. 5, no. 5, pp. 353-360.
Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM et al. Impact of cancer-related fatigue on the lives of patients: New findings from the fatigue coalition. Oncologist. 2000;5(5):353-360.
Curt, G. A. ; Breitbart, W. ; Cella, D. ; Groopman, J. E. ; Horning, S. J. ; Itri, L. M. ; Johnson, D. H. ; Miaskowski, C. ; Scherr, S. L. ; Portenoy, R. K. ; Vogelzang, N. J. / Impact of cancer-related fatigue on the lives of patients : New findings from the fatigue coalition. In: Oncologist. 2000 ; Vol. 5, No. 5. pp. 353-360.
@article{0cc36d52fea4471aaa6e4170898bc18f,
title = "Impact of cancer-related fatigue on the lives of patients: New findings from the fatigue coalition",
abstract = "Purpose. This survey was designed to confirm the prevalence and duration of fatigue in the cancer population and to assess its physical, mental, social, and economic impacts on the lives of patients and caregivers. Patients and Methods. A 25-minute telephone interview was completed with 379 cancer patients having a prior history of chemotherapy. Patients were recruited from a sample of 6,125 households in the United States identified as having a member with cancer. The median patient age was 62 years, and 79{\%} of respondents were women. Patients reporting fatigue at least a few times a month were asked a series of questions to better describe their fatigue and its impact on quality of life. Results. Seventy-six percent of patients experienced fatigue at least a few days each month during their most recent chemotherapy; 30{\%} experienced fatigue on a daily basis. Ninety-one percent of those who experienced fatigue reported that it prevented a 'normal' life, and 88{\%} indicated that fatigue caused an alteration in their daily routine. Fatigue made it more difficult to participate in social activities and perform typical cognitive tasks. Of the 177 patients who were employed, 75{\%} changed their employment status as a result of fatigue. Furthermore, 65{\%} of patients indicated that their fatigue resulted in their caregivers taking at least one day (mean, 4.5 days) off work in a typical month. Physicians were the health care professionals most commonly consulted (79{\%}) to discuss fatigue. Bed rest/relaxation was the most common treatment recommendation (37{\%}); 40{\%} of patients were not offered any recommendations. Conclusions. Cancer-related fatigue is common among cancer patients who have received chemotherapy and results in substantial adverse physical, psychosocial, and economic consequences for both patients and caregivers. Given the impact of fatigue, treatment options should be routinely considered in the care of patients with cancer.",
keywords = "Asthenia, Cancer, Chemotherapy, Fatigue, Fatigue Coalition, Quality of life",
author = "Curt, {G. A.} and W. Breitbart and D. Cella and Groopman, {J. E.} and Horning, {S. J.} and Itri, {L. M.} and Johnson, {D. H.} and C. Miaskowski and Scherr, {S. L.} and Portenoy, {R. K.} and Vogelzang, {N. J.}",
year = "2000",
language = "English (US)",
volume = "5",
pages = "353--360",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "5",

}

TY - JOUR

T1 - Impact of cancer-related fatigue on the lives of patients

T2 - New findings from the fatigue coalition

AU - Curt, G. A.

AU - Breitbart, W.

AU - Cella, D.

AU - Groopman, J. E.

AU - Horning, S. J.

AU - Itri, L. M.

AU - Johnson, D. H.

AU - Miaskowski, C.

AU - Scherr, S. L.

AU - Portenoy, R. K.

AU - Vogelzang, N. J.

PY - 2000

Y1 - 2000

N2 - Purpose. This survey was designed to confirm the prevalence and duration of fatigue in the cancer population and to assess its physical, mental, social, and economic impacts on the lives of patients and caregivers. Patients and Methods. A 25-minute telephone interview was completed with 379 cancer patients having a prior history of chemotherapy. Patients were recruited from a sample of 6,125 households in the United States identified as having a member with cancer. The median patient age was 62 years, and 79% of respondents were women. Patients reporting fatigue at least a few times a month were asked a series of questions to better describe their fatigue and its impact on quality of life. Results. Seventy-six percent of patients experienced fatigue at least a few days each month during their most recent chemotherapy; 30% experienced fatigue on a daily basis. Ninety-one percent of those who experienced fatigue reported that it prevented a 'normal' life, and 88% indicated that fatigue caused an alteration in their daily routine. Fatigue made it more difficult to participate in social activities and perform typical cognitive tasks. Of the 177 patients who were employed, 75% changed their employment status as a result of fatigue. Furthermore, 65% of patients indicated that their fatigue resulted in their caregivers taking at least one day (mean, 4.5 days) off work in a typical month. Physicians were the health care professionals most commonly consulted (79%) to discuss fatigue. Bed rest/relaxation was the most common treatment recommendation (37%); 40% of patients were not offered any recommendations. Conclusions. Cancer-related fatigue is common among cancer patients who have received chemotherapy and results in substantial adverse physical, psychosocial, and economic consequences for both patients and caregivers. Given the impact of fatigue, treatment options should be routinely considered in the care of patients with cancer.

AB - Purpose. This survey was designed to confirm the prevalence and duration of fatigue in the cancer population and to assess its physical, mental, social, and economic impacts on the lives of patients and caregivers. Patients and Methods. A 25-minute telephone interview was completed with 379 cancer patients having a prior history of chemotherapy. Patients were recruited from a sample of 6,125 households in the United States identified as having a member with cancer. The median patient age was 62 years, and 79% of respondents were women. Patients reporting fatigue at least a few times a month were asked a series of questions to better describe their fatigue and its impact on quality of life. Results. Seventy-six percent of patients experienced fatigue at least a few days each month during their most recent chemotherapy; 30% experienced fatigue on a daily basis. Ninety-one percent of those who experienced fatigue reported that it prevented a 'normal' life, and 88% indicated that fatigue caused an alteration in their daily routine. Fatigue made it more difficult to participate in social activities and perform typical cognitive tasks. Of the 177 patients who were employed, 75% changed their employment status as a result of fatigue. Furthermore, 65% of patients indicated that their fatigue resulted in their caregivers taking at least one day (mean, 4.5 days) off work in a typical month. Physicians were the health care professionals most commonly consulted (79%) to discuss fatigue. Bed rest/relaxation was the most common treatment recommendation (37%); 40% of patients were not offered any recommendations. Conclusions. Cancer-related fatigue is common among cancer patients who have received chemotherapy and results in substantial adverse physical, psychosocial, and economic consequences for both patients and caregivers. Given the impact of fatigue, treatment options should be routinely considered in the care of patients with cancer.

KW - Asthenia

KW - Cancer

KW - Chemotherapy

KW - Fatigue

KW - Fatigue Coalition

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0033779589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033779589&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 353

EP - 360

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 5

ER -